Matthew C. Pickering

机构：Imperial Valley College, Centre for Inflammation Research, Imperial College London · ORCID：0000-0002-1153-0192

发表论文 300 篇 · 总被引 14357 次 · h-index 64

代表论文

Efficacy and Safety of Pegcetacoplan in Kidney Transplant Recipients With Recurrent Complement 3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis (2024 · Kidney International Reports · 被引 50)
Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study (2025 · The Lancet · 被引 42)
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN (2025 · New England Journal of Medicine · 被引 40)
VALIANT: A Randomized, Multicenter, Double-Blind, Placebo (PBO)-Controlled, Phase 3 Trial of Pegcetacoplan for Patients with Native or Post-transplant Recurrent Glomerulopathy (C3G) or Primary Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) (2024 · Journal of the American Society of Nephrology · 被引 24)
Current and Emerging Therapies for C3 Glomerulopathy and Primary (Idiopathic) Immune Complex Membranoproliferative Glomerulonephritis (2025 · Kidney International Reports · 被引 7)
Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative GN (2025 · Clinical Journal of the American Society of Nephrology · 被引 6)